Tumor regression after neoadjuvant hormonal therapy in high risk prostate cancer: pathological outcomes from a ...
High-risk localized prostate cancer (HRLPC) commonly progresses to metastatic disease after local treatment. Neoadjuvant androgen deprivation therapy (nADT) before radical prostatectomy (RP) has recently been suggested to improve early oncological outcomes …